SCHEMBL2495680

SCHEMBL2495680

CNc1ccccc1[C](c1ccccc1NC)c1ccccc1NC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.59
KDM4E B2RXH2 3/20 0.59
ATM Q13315 1/20 0.59
ALDH1A1 P00352 3/20 0.46
MAPT P10636 3/20 0.46
RECQL P46063 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
USP2 O75604 1/20 0.46
HPGD P15428 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HSD17B10 Q99714 1/20 0.46
IDO1 P14902 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
FABP3 P05413 1/20 0.39
FABP4 P15090 1/20 0.39
FABP5 Q01469 1/20 0.39
EGFR P00533 1/20 0.38
PABPC1 P11940 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8628627 0.80 POLB (0.67) POLBKDM4EATMALDH1A1MAPT
SCHEMBL27276860 0.78 POLB (0.53) POLBKDM4EATMALDH1A1MAPT
N-Methylanthranilic Acid SCHEMBL29381752 0.78 KDM4E (0.64) POLBKDM4EATMALDH1A1MAPT
SCHEMBL1106863 0.78 POLB (0.53) POLBKDM4EATMALDH1A1MAPT
N-Methylanthranilic Acid SCHEMBL130356 0.78 KDM4E (0.64) POLBKDM4EATMALDH1A1MAPT
SCHEMBL8574363 0.78 POLB (0.53) POLBKDM4EATMALDH1A1MAPT
SCHEMBL31087257 0.78 POLB (0.64) POLBKDM4EATMALDH1A1MAPT
SCHEMBL6964053 0.78 KDM4E (0.64) POLBKDM4EATMALDH1A1MAPT
SCHEMBL848499 0.78 POLB (0.64) POLBKDM4EATMALDH1A1MAPT
SCHEMBL2270403 0.77 POLB (0.52) POLBKDM4EATMALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH POLB 3212/4885KDM4E 2772/4885ATM 2913/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 POLB 3196/4885KDM4E 3096/4885ATM 2976/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R POLB 3183/4885KDM4E 3125/4885ATM 2836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.